KPTI vs VRTX: Which Stock is Better?
Side-by-side comparison of Karyopharm Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026
KPTI
Karyopharm Therapeutics Inc
$8.45
VRTX
Vertex Pharmaceuticals Inc
$444.28
Key Metrics Comparison
| Metric | KPTI | VRTX | Winner |
|---|---|---|---|
| Market Cap | $186.66M | $111.93B | VRTX |
| P/E Ratio | N/A | 28.74 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 0.1% | 0.1% | KPTI |
| Gross Margin | 9.9% | 53.7% | VRTX |
Analyze KPTI
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KPTI or VRTX a better investment?
Comparing KPTI and VRTX: Karyopharm Therapeutics Inc has a market cap of $186.66M while Vertex Pharmaceuticals Inc has $111.93B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KPTI and VRTX?
KPTI (Karyopharm Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KPTI or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KPTI or VRTX?
KPTI has higher revenue growth at 0.1% vs 0.1% for VRTX.
Which company is more profitable: KPTI or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 9.9% for KPTI.
Which is the larger company: KPTI or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $111.93B compared to $186.66M for KPTI.
Should I buy KPTI or VRTX in 2026?
Both KPTI and VRTX have investment merit. KPTI trades at $8.45 while VRTX trades at $444.28. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KPTI and VRTX stock?
Key differences: Market Cap ($186.66M vs $111.93B), P/E Ratio (N/A vs 28.7x), Revenue Growth (0.1% vs 0.1%), Gross Margin (9.9% vs 53.7%).